Medications

FDA approves admelog for diabetes

(HealthDay)—Admelog (insulin lispro), a short-acting form of insulin, has been approved by the U.S. Food and Drug Administration to treat patients aged 3 years and older with either type of diabetes.

Dec 12, 2017
popularity0 comments 0